TF
NVO

TIAA FSB’s Novo Nordisk NVO Stock Holding History

TIAA FSB’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$735K Sell
9,080
-968
-10% -$79.1K ﹤0.01% 364
2023
Q1 		$800K Buy
10,048
+292
+3% +$20.7K ﹤0.01% 346
2022
Q4 		$660K Sell
9,756
-926
-9% -$54.3K ﹤0.01% 374
2022
Q3 		$532K Buy
10,682
+54
+0.5% +$2.89K ﹤0.01% 397
2022
Q2 		$592K Sell
10,628
-37,514
-78% -$2.08M ﹤0.01% 397
2022
Q1 		$2.67M Sell
48,142
-106
-0.2% -$5.44K 0.01% 237
2021
Q4 		$2.7M Sell
48,248
-2,926
-6% -$159K 0.01% 231
2021
Q3 		$2.46M Buy
51,174
+1,716
+3% +$83K 0.01% 235
2021
Q2 		$2.07M Buy
49,458
+290
+0.6% +$11.2K 0.01% 255
2021
Q1 		$1.66M Buy
49,168
+2,212
+5% +$78.8K 0.01% 265
2020
Q4 		$1.64M Buy
46,956
+62
+0.1% +$2.14K 0.01% 260
2020
Q3 		$1.63M Sell
46,894
-6,108
-12% -$204K 0.01% 231
2020
Q2 		$1.74M Sell
53,002
-2,828
-5% -$90.2K 0.01% 227
2020
Q1 		$1.68M Sell
55,830
-2,846
-5% -$84.7K 0.01% 211
2019
Q4 		$1.7M Buy
58,676
+452
+0.8% +$12.5K 0.01% 238
2019
Q3 		$1.5M Buy
58,224
+706
+1% +$17.9K 0.01% 238
2019
Q2 		$1.47M Buy
57,518
+35,446
+161% +$876K 0.01% 225
2019
Q1 		$577K Sell
22,072
-2,802
-11% -$68.9K ﹤0.01% 294
2018
Q4 		$573K Sell
24,874
-30
-0.1% -$667 ﹤0.01% 294
2018
Q3 		$587K Sell
24,904
-14
-0.1% -$342 ﹤0.01% 310
2018
Q2 		$575K Sell
24,918
-218
-0.9% -$5.18K ﹤0.01% 308
2018
Q1 		$619K Sell
25,136
-3,344
-12% -$87.8K ﹤0.01% 320
2017
Q4 		$764K Buy
28,480
+1,322
+5% +$33.6K ﹤0.01% 327
2017
Q3 		$654K Sell
27,158
-282
-1% -$6.37K ﹤0.01% 337
2017
Q2 		$588K Buy
+27,440
New +$554K ﹤0.01% 335

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TIAA FSB's NVO Position: Q2 2023 in Review

TIAA FSB reduced its Novo Nordisk (NVO) stake by 9.6% in Q2 2023, selling an estimated $79.1K and leaving 9,080 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

TIAA FSB first reported a position in NVO in Q2 2017 and has held it in 25 quarters since. The position peaked at $2.7M in Q4 2021. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • TIAA FSB held 9,080 shares of Novo Nordisk worth $735K as of Q2 2023.
  • TIAA FSB sold 968 Novo Nordisk shares in Q2 2023, an estimated $79.1K.
  • Novo Nordisk made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #364 holding.
  • TIAA FSB first reported a position in Novo Nordisk in Q2 2017 and has held it in 25 quarters since.
  • TIAA FSB's Novo Nordisk position peaked at $2.7M in Q4 2021.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.